Administration of dipeptidyl peptidase inhibitors

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/513 (2006.01) A61P 3/10 (2006.01) A61P 5/50 (2006.01) A61P 31/18 (2006.01) A61P 35/00 (2006.01)

Patent

CA 2663279

Pharmaceutical compositions comprising 2-[6-(3-Amino-piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethyl]-4-fluoro-benzonitrile and pharmaceutically acceptable salts thereof are provided as well as kits and articles of manufacture comprising the pharmaceutical compositions as well as methods of using the pharmaceutical compositions.

L'invention concerne des compositions pharmaceutiques comprenant du 2-[6-(3-amino-pipéridin-1-yl)-3-méthyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylméthyl]-4-fluoro-benzonitrile et des sels pharmaceutiquement acceptables de ce composé, ainsi que des trousses et des articles de fabrication comprenant ces compositions pharmaceutiques et des méthodes d'utilisation desdites compositions pharmaceutiques.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Administration of dipeptidyl peptidase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Administration of dipeptidyl peptidase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Administration of dipeptidyl peptidase inhibitors will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1488478

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.